Researchers from MSK, Weill Cornell Medical College, and the Herbert Irving Comprehensive Cancer Center of Columbia University convened for the SPORE’s Annual External Advisory Board Meeting.
Anas Younes, Co-Director of the MSK Lymphoma SPORE, provided an update on a project investigating the development of mechanism-based therapy for diffuse large B cell lymphoma.
The Annual External Advisory Board Meeting for the MSK SPORE in Lymphoma was held on June 6, 2018. Investigators, collaborators, and advisory board members came together to discuss strengths, weaknesses, shortcomings and successes of the research effort over the second year of the grant period. Updates were given on the progress of SPORE projects, and information was presented on the status of the SPORE cores as well as the year’s projects in the Career Enhancement and Developmental Research Programs.